Literature DB >> 29275077

Human Mycobacterium bovis infection in Castile and León (Spain), 2006-2015.

Teresa Nebreda-Mayoral1, M Fé Brezmes-Valdivieso2, Nieves Gutiérrez-Zufiaurre3, Susana García-de Cruz4, Cristina Labayru-Echeverría5, Ramiro López-Medrano6, Luis López-Urrutia-Lorente7, Almudena Tinajas-Puertas8, Octavio Rivero-Lezcano9.   

Abstract

INTRODUCTION: The annual incidence of tuberculosis (TB) from Mycobacterium bovis in humans has considerably declined in industrialised countries since the early twentieth century. The objective of this study was to determine the epidemiological, clinical and microbiological characteristics of patients with this illness in Castile and León (CyL).
METHODS: Retrospective study of all M. bovis TB cases in CyL over a 10-year period, comparing the risk factors, the epidemiology and the clinical course between pulmonary (PTB) and extrapulmonary TB (EPTB).
RESULTS: 75 cases of TB were due to M. bovis: 45 PTB and 31 EPTB. The annual incidence of TB due to M. bovis was 0.3 cases per 100,000. It remained stable between the first and second five-year period (0.27 vs. 0.33, p=0.656). However, the overall incidence of TB fell in both five-year periods (13.58 vs. 10.71, p<0.0001). The mean age was 66.2+21.3 years, mainly men (63%) and Spanish patients (92%). PTB was significantly more frequent in men, aged over 66 years, with immunosuppressive conditions or who were smokers. Mortality was 9%, associated with higher age, immunosuppression or treatment different from that recommended by the WHO.
CONCLUSIONS: The incidence of M. bovis TB in CyL was higher than that for Spain and for other European countries, and remained stable despite the decreased the TB due to MTC. It affected mostly Spanish-born patients who lived in rural areas and with a high mean age.
Copyright © 2017 Elsevier España, S.L.U. and Sociedad Española de Enfermedades Infecciosas y Microbiología Clínica. All rights reserved.

Entities:  

Keywords:  Extrapulmonary tuberculosis; Factores de riesgo; Incidence; Incidencia; Mycobacterium bovis; Pulmonary tuberculosis; Risk factors; Tuberculosis extrapulmonar; Tuberculosis pulmonar

Mesh:

Year:  2017        PMID: 29275077     DOI: 10.1016/j.eimc.2017.11.018

Source DB:  PubMed          Journal:  Enferm Infecc Microbiol Clin (Engl Ed)        ISSN: 2529-993X


  5 in total

1.  Transcriptome array screening and verification of oral leukoplakia carcinogenesis-related hypoxia-responsive gene and microRNA.

Authors:  Lin-Jun Shi; Xi Yang; Su-Ning Wu; Wei Liu
Journal:  Hua Xi Kou Qiang Yi Xue Za Zhi       Date:  2021-02-01

2.  One Health and surveillance of zoonotic tuberculosis in selected low-income, middle-income and high-income countries: A systematic review.

Authors:  Rodrigo de Macedo Couto; Giulia Osório Santana; Otavio T Ranzani; Eliseu Alves Waldman
Journal:  PLoS Negl Trop Dis       Date:  2022-06-06

3.  Mycobacterium bovis Pulmonary Tuberculosis after Ritual Sheep Sacrifice in Tunisia.

Authors:  Jamal Saad; Sophie Baron; Jean-Christophe Lagier; Michel Drancourt; Phillipe Gautret
Journal:  Emerg Infect Dis       Date:  2020-07       Impact factor: 6.883

4.  Polyresistant Mycobacterium bovis Infection in Human and Sympatric Sheep, Spain, 2017-2018.

Authors:  Bernat Pérez de Val; Beatriz Romero; María Teresa Tórtola; Laura Herrera León; Pilar Pozo; Irene Mercader; Jose Luís Sáez; Mariano Domingo; Enric Vidal
Journal:  Emerg Infect Dis       Date:  2021-04       Impact factor: 6.883

5.  Whole Genome Sequence Analysis of Mycobacterium bovis Cattle Isolates, Algeria.

Authors:  Fatah Tazerart; Jamal Saad; Naima Sahraoui; Djamel Yala; Abdellatif Niar; Michel Drancourt
Journal:  Pathogens       Date:  2021-06-24
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.